turtlepower Share Friday, October 08, 2010 8:17:24 AM Re: DewDiligence post# 97437 Tweet Post # of 105877
Boehringer Ends Female Desire Drug Development After FDA's Safety Query By Naomi Kresge - Oct 8, 2010 3:55 AM ET Tweet LinkedIn Share Print Email Oct. 8 (Bloomberg) - Boehringer Ingelheim GmbH abandoned development of its female desire drug flibanserin after U.S. regulators said the pill wasn’t proven to be safe and effective.
Great. Just great. So now the whole country is going to be chock-full of obese, frigid women. As a result, no matter where you travel in this great land it will all appear like Milwaukee.
AI
